Medical Economics December 2, 2024
Richard Payerchin

Key Takeaways

  • Side effects of GLP-1 RA drugs influence patient adherence, despite controlled research guiding physicians.
  • Real-world experiences may lead to treatment discontinuation due to physical side effects.
  • Cost and availability significantly impact patient willingness to continue treatment.
  • Robert Kushner, MD, highlights these factors based on his expertise in obesity and nutrition.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Side effects play a role in a patient’s desire to use GLP-1 RA drugs for weight loss or other health conditions....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Pharma / Biotech, Physician, Provider, Trends
AbbVie to write off $3.5B over failed schizophrenia drug
Drug Price Negotiation Requires Oversight To Protect Older Americans
5 questions facing emerging biotech in 2025
Lantheus (LNTH) Acquires Life Molecular Imaging for $750M
New Weight Loss Drugs May Fight Obesity-Related Cancer, Too

Share This Article